A Methylated Oligonucleotide Inhibits IGF2 Expression and Enhances Survival in a Model of Hepatocellular Carcinoma

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2003 Jan 18

PMID 12531883

Citations 35

Authors

Xiaoming Yao

Ji-Fan Hu

Mark Daniels

Hadas Shiran

Xiangjun Zhou

Huifan Yan

Hongqi Lu

Zhilan Zeng

Qingxue Wang

Tao Li

Andrew R Hoffman

Affiliations

Soon will be listed here.

Abstract

IGF-II is a mitogenic peptide that has been implicated in hepatocellular oncogenesis. Since the silencing of gene expression is frequently associated with cytosine methylation at cytosine-guanine (CpG) dinucleotides, we designed a methylated oligonucleotide (MON1) complementary to a region encompassing IGF2 promoter P4 in an attempt to induce DNA methylation at that locus and diminish IGF2 mRNA levels. MON1 specifically inhibited IGF2 mRNA accumulation in vitro, whereas an oligonucleotide (ON1) with the same sequence but with nonmethylated cytosines had no effect on IGF2 mRNA abundance. MON1 treatment led to the specific induction of de novo DNA methylation in the region of IGF2 promoter hP4. Cells from a human hepatocellular carcinoma (HCC) cell line, Hep 3B, were implanted into the livers of nude mice, resulting in the growth of large tumors. Animals treated with MON1 had markedly prolonged survival as compared with those animals treated with saline or a truncated methylated oligonucleotide that did not alter IGF2 mRNA levels in vitro. This study demonstrates that a methylated sense oligonucleotide can be used to induce epigenetic changes in the IGF2 gene and that inhibition of IGF2 mRNA accumulation may lead to enhanced survival in a model of HCC.

Citing Articles

Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.

Kumar D, Das M, Oberg A, Sahoo D, Wu P, Sauceda C Adv Sci (Weinh). 2022; 9(21):e2105120.

PMID: 35615981 PMC: 9313545. DOI: 10.1002/advs.202105120.

Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1.

Liu M, Zhong Y, Shao J, Zhang C, Shi C Cancer Biol Ther. 2020; 21(11):1041-1050.

PMID: 33081566 PMC: 7678937. DOI: 10.1080/15384047.2020.1824478.

The Good, the Bad, the Question- in Hepatocellular Carcinoma.

Tietze L, Kessler S Cancers (Basel). 2020; 12(5).

PMID: 32429417 PMC: 7281302. DOI: 10.3390/cancers12051261.

Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis.

Vacante F, Senesi P, Montesano A, Paini S, Luzi L, Terruzzi I Int J Endocrinol. 2019; 2019:7570146.

PMID: 30774659 PMC: 6350585. DOI: 10.1155/2019/7570146.

14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.

Tang Y, Zhang Y, Wang C, Sun Z, Li L, Dong J Cancer Med. 2018; 7(11):5543-5553.

PMID: 30358169 PMC: 6247021. DOI: 10.1002/cam4.1512.

References

Hu J, Nguyen P, Pham N, Vu T, Hoffman A . Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation. Mol Endocrinol. 1998; 11(13):1891-8. DOI: 10.1210/mend.11.13.0030. View

Song S, Jong H, Choi H, Inoue H, Tanabe T, Kim N . Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. Cancer Res. 2001; 61(11):4628-35. View

Hu J, Oruganti H, Vu T, Hoffman A . Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol Endocrinol. 1998; 12(2):220-32. DOI: 10.1210/mend.12.2.0062. View

Wassenegger M, Pelissier T . A model for RNA-mediated gene silencing in higher plants. Plant Mol Biol. 1998; 37(2):349-62. DOI: 10.1023/a:1005946720438. View

Jones P, Veenstra G, Wade P, Vermaak D, Kass S, Landsberger N . Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998; 19(2):187-91. DOI: 10.1038/561. View

Schweizer J, Goret F, Pourcel C . Control of expression and methylation of a hepatitis B virus transgene by strain-specific modifiers. DNA Cell Biol. 1998; 17(5):427-35. DOI: 10.1089/dna.1998.17.427. View

Bu W, Tang Z, Sun F, Ye S, Liu K, Xue Q . Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. Hepatogastroenterology. 1998; 45(22):1056-61. View

Hu J, Oruganti H, Vu T, Hoffman A . The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene. Biochem Biophys Res Commun. 1998; 251(2):403-8. DOI: 10.1006/bbrc.1998.9401. View

Pulford D, Falls J, Killian J, Jirtle R . Polymorphisms, genomic imprinting and cancer susceptibility. Mutat Res. 1999; 436(1):59-67. DOI: 10.1016/s1383-5742(98)00018-0. View

10.

Cameron E, Bachman K, Myohanen S, Herman J, Baylin S . Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999; 21(1):103-7. DOI: 10.1038/5047. View

11.

Sparwasser T, Hultner L, Koch E, Luz A, Lipford G, Wagner H . Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J Immunol. 1999; 162(4):2368-74. View

12.

Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi B, Cedar H . DNA methylation represses transcription in vivo. Nat Genet. 1999; 22(2):203-6. DOI: 10.1038/9727. View

13.

Bell A, Felsenfeld G . Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature. 2000; 405(6785):482-5. DOI: 10.1038/35013100. View

14.

Karpf A, Peterson P, Rawlins J, Dalley B, Yang Q, Albertsen H . Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc Natl Acad Sci U S A. 1999; 96(24):14007-12. PMC: 24181. DOI: 10.1073/pnas.96.24.14007. View

15.

Lee O, Bae S, Bae M, Lee Y, Moon E, Cha H . Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer. 2000; 82(2):385-91. PMC: 2363289. DOI: 10.1054/bjoc.1999.0931. View

16.

Pelissier T, Wassenegger M . A DNA target of 30 bp is sufficient for RNA-directed DNA methylation. RNA. 2000; 6(1):55-65. PMC: 1369893. DOI: 10.1017/s135583820099201x. View

17.

Tycko B . Epigenetic gene silencing in cancer. J Clin Invest. 2000; 105(4):401-7. PMC: 289180. DOI: 10.1172/JCI9462. View

18.

Vu T, Li T, Nguyen D, Nguyen B, Yao X, Hu J . Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics. 2000; 64(2):132-43. DOI: 10.1006/geno.1999.6094. View

19.

Stein C . Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments. Biochim Biophys Acta. 2000; 1489(1):45-52. DOI: 10.1016/s0167-4781(99)00143-8. View

20.

Toulme J, Di Primo C, Moreau S . Modulation of RNA function by oligonucleotides recognizing RNA structure. Prog Nucleic Acid Res Mol Biol. 2001; 69:1-46. DOI: 10.1016/s0079-6603(01)69043-3. View